These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 210185

  • 1. Characterization of functional receptors for somatostatin in rat pituitary cells in culture.
    Schonbrunn A, Tashjian H.
    J Biol Chem; 1978 Sep 25; 253(18):6473-83. PubMed ID: 210185
    [Abstract] [Full Text] [Related]

  • 2. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
    Presky DH, Schonbrunn A.
    Mol Pharmacol; 1988 Nov 25; 34(5):651-8. PubMed ID: 2904115
    [Abstract] [Full Text] [Related]

  • 3. Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.
    Presky DH, Schonbrunn A.
    J Cell Biol; 1986 Mar 25; 102(3):878-88. PubMed ID: 2869047
    [Abstract] [Full Text] [Related]

  • 4. Pituitary somatostatin receptors. Characterization by binding with a nondegradable peptide analogue.
    Aguilera G, Parker DS.
    J Biol Chem; 1982 Feb 10; 257(3):1134-7. PubMed ID: 6120162
    [Abstract] [Full Text] [Related]

  • 5. Characterization of bombesin receptors in a rat pituitary cell line.
    Westendorf JM, Schonbrunn A.
    J Biol Chem; 1983 Jun 25; 258(12):7527-35. PubMed ID: 6305945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells.
    Schonbrunn A, Rorstad OP, Westendorf JM, Martin JB.
    Endocrinology; 1983 Nov 25; 113(5):1559-67. PubMed ID: 6138246
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture.
    Richardson UI, Schonbrunn A.
    Endocrinology; 1981 Jan 25; 108(1):281-90. PubMed ID: 6109620
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin receptors on rat anterior pituitary membranes.
    Enjalbert A, Tapia-Arancibia L, Rieutort M, Brazeau P, Kordon C, Epelbaum J.
    Endocrinology; 1982 May 25; 110(5):1634-40. PubMed ID: 6122557
    [Abstract] [Full Text] [Related]

  • 10. Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. Evidence for coupling of Ni to decreases in intracellular free calcium.
    Koch BD, Dorflinger LJ, Schonbrunn A.
    J Biol Chem; 1985 Oct 25; 260(24):13138-45. PubMed ID: 2865257
    [Abstract] [Full Text] [Related]

  • 11. Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs.
    Reubi JC, Perrin M, Rivier J, Vale W.
    Regul Pept; 1982 Aug 25; 4(3):141-6. PubMed ID: 6127756
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhbition of cell proliferation.
    Schonbrunn A, Krasnoff M, Westendorf JM, Tashjian AH.
    J Cell Biol; 1980 Jun 25; 85(3):786-97. PubMed ID: 6771298
    [Abstract] [Full Text] [Related]

  • 13. Characterization of pituitary membrane receptors for somatostatin in the rat.
    Srikant CB, Patel YC.
    Endocrinology; 1982 Jun 25; 110(6):2138-44. PubMed ID: 6122562
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
    Moyse E, Le Dafniet M, Epelbaum J, Pagesy P, Peillon F, Kordon C, Enjalbert A.
    J Clin Endocrinol Metab; 1985 Jul 25; 61(1):98-103. PubMed ID: 2860120
    [Abstract] [Full Text] [Related]

  • 15. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I, Rubinstein M, Gaylinn BD, Hill D, Arany E, Low MJ, Díaz-Torga G, Becu-Villalobos D.
    J Endocrinol; 2006 Sep 25; 190(3):611-9. PubMed ID: 17003262
    [Abstract] [Full Text] [Related]

  • 16. Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.
    Srikant CB, Heisler S.
    Endocrinology; 1985 Jul 25; 117(1):271-8. PubMed ID: 2861078
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin and regulation of prolactin secretion.
    Enjalbert A, Bertrand P, Le Dafniet M, Epelbaum J, Hugues JN, Kordon C, Moyse E, Peillon F, Shu C.
    Psychoneuroendocrinology; 1986 Jul 25; 11(2):155-65. PubMed ID: 2875480
    [Abstract] [Full Text] [Related]

  • 18. Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor.
    Osborne R, Tashjian AH.
    Cancer Res; 1982 Nov 25; 42(11):4375-81. PubMed ID: 6127158
    [No Abstract] [Full Text] [Related]

  • 19. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov 25; 113(5):1541-50. PubMed ID: 6194974
    [Abstract] [Full Text] [Related]

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan 25; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.